N V Jacobus - Concepedia

Author

N V Jacobus

Also Known As

N Jacobus, N V Jacobus, N. Jacobus, N. V Jacobus, N. V. JACOBUS, N. V. Jacobus, N.V. Jacobus, N. V. Jacobus, NILDA V. JACOBUS, Nilda V. Jacobus

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Tufts Medical Center Tufts University University of Michigan Duke Medical Center United States Department of Veterans Affairs

About

N V Jacobus is an author at Tufts Medical Center specializing in medicine, microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	41	3.1K
2	Health Sciences	25	31	2.6K
3	Biochemistry	6	6	640
4	Natural Sciences	2	2	35
5	Engineering	1	1	16

N V Jacobus

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Antimicrobial substance from a human Lactobacillus strain M Silva, N V Jacobus, Carl F. Deneke, Antimicrobial Agents and Chemotherapy Antimicrobial SubstanceInhibitory ActivityAntimicrobial SusceptibilityHealth SciencesAntibiotics	1987	558
In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- <i>t</i> -Butylglycylamido Derivative of Minocycline (GAR-936) Peter J. Petersen, N V Jacobus, Jason Weiss, Antimicrobial Agents and Chemotherapy Pharmaceutical ScienceGlycobiologyRibosomal ProtectionAntimicrobial ChemotherapyAntibiotic Resistance	1999	410
Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data (2005–2007) David R. Snydman, N V Jacobus, Laura A. McDermott, Clinical Infectious Diseases	2010	177
National Survey on the Susceptibility of <i>Bacteroides fragilis</i> Group: Report and Analysis of Trends in the United States from 1997 to 2004 David R. Snydman, N V Jacobus, L. A. McDermott, Antimicrobial Agents and Chemotherapy	2007	168
Superoxide dismutase in anaerobic bacteria of clinical significance Francis P. Tally, Barry R. Goldin, N V Jacobus, Infection and Immunity Enzyme LevelBiochemistryBacteriologyMicrobial EcologyOxygen Tolerance	1977	147
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation G J Cuchural, Francis P. Tally, N V Jacobus, Antimicrobial Agents and Chemotherapy Antibiotic ResistanceUnited StatesDrug ResistanceMedical MicrobiologyHealthcare-associated Infection	1988	144
Susceptibility of Anaerobes to Cefoxitin and Other Cephalosporins Francis P. Tally, N V Jacobus, John G. Bartlett, Antimicrobial Agents and Chemotherapy	1975	133
In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines R. T. TESTA, Peter J. Petersen, N V Jacobus, Antimicrobial Agents and Chemotherapy	1993	123
Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006–2009 David R. Snydman, N V Jacobus, L. A. McDermott, Anaerobe Related SpeciesSpecial AttentionAntimicrobial Resistance GeneAntimicrobial SusceptibilityHealth Sciences	2011	117
Susceptibility of the Bacteroides fragilis group in the United States in 1981 Francis P. Tally, G J Cuchural, N V Jacobus, Antimicrobial Agents and Chemotherapy Susceptibility TestingResistance RateAntimicrobial ChemotherapyAntibiotic ResistanceUnited States	1983	109

Page 1